The George Washington Cancer Center | Strategic Alliance Partners

Latest from The George Washington Cancer Center


Dr. Smith on PI3K Inhibitors in CLL

November 02, 2019

Mitchell R. Smith, MD, PhD, division director, Cancer and Blood Disorders, and professor of medicine, GW Cancer Center, discusses the use of PI3K inhibitors in chronic lymphocytic leukemia (CLL).

x